{
 "awd_id": "0320485",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Standard Grant",
 "awd_titl_txt": "SBIR Phase I:     Development of Agents to Promote Cellular Ga-67 (Gallium-67) Uptake",
 "cfda_num": "47.084",
 "org_code": "15030000",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "Om P. Sahai",
 "awd_eff_date": "2003-07-01",
 "awd_exp_date": "2004-03-31",
 "tot_intn_awd_amt": 99999.0,
 "awd_amount": 99999.0,
 "awd_min_amd_letter_date": "2003-06-20",
 "awd_max_amd_letter_date": "2004-01-08",
 "awd_abstract_narration": "This Small Business Innovation Research (SBIR) Phase I project is proposes to develop new pharmaceutical agents to selectively enhance tumor imaging using gallium (Ga-67).  Ga-67 has been widely used in tumor imaging and clinical medicine due to significant advantages in terms of low cost, ease of use and long life. However, the use of Ga -67 is currently limited, mainly due to varying tumor avidity and high dose requirements needed to achieve high signal-to-background ratios in non-gallium avid tumors. Increasing the selective uptake of gallium by tumor cells will dramatically improve gallium imaging, resulting in the development of an innovative, sensitive, and low-cost tumor detection tool. This Phase I program will focus on designing, preparing and evaluating novel nitrosipine derivatives with the potential to drastically increase the uptake of Ga-67 by tumor cells. \r\n\r\nThe commercial application of this project is in the area of tumor imaging and oncology.\r\n",
 "awd_arra_amount": 0.0,
 "dir_abbr": "TIP",
 "org_dir_long_name": "Directorate for Technology, Innovation, and Partnerships",
 "div_abbr": "TI",
 "org_div_long_name": "Translational Impacts",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "Takuji",
   "pi_last_name": "Tsukamoto",
   "pi_mid_init": "",
   "pi_sufx_name": "",
   "pi_full_name": "Takuji Tsukamoto",
   "pi_email_addr": "taku@chemica.com",
   "nsf_id": "000149298",
   "pi_start_date": "2003-06-20",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "Chemica Technologies Inc",
  "inst_street_address": "2611 SW 3RD AVE STE 250F",
  "inst_street_address_2": "",
  "inst_city_name": "PORTLAND",
  "inst_state_code": "OR",
  "inst_state_name": "Oregon",
  "inst_phone_num": "5033520262",
  "inst_zip_code": "972014957",
  "inst_country_name": "United States",
  "cong_dist_code": "01",
  "st_cong_dist_code": "OR01",
  "org_lgl_bus_name": "CHEMICA TECHNOLOGIES, INC",
  "org_prnt_uei_num": "",
  "org_uei_num": "J1RCKLNS64L7"
 },
 "perf_inst": {
  "perf_inst_name": "Chemica Technologies Inc",
  "perf_str_addr": "2611 SW 3RD AVE STE 250F",
  "perf_city_name": "PORTLAND",
  "perf_st_code": "OR",
  "perf_st_name": "Oregon",
  "perf_zip_code": "972014957",
  "perf_ctry_code": "US",
  "perf_cong_dist": "01",
  "perf_st_cong_dist": "OR01",
  "perf_ctry_name": "",
  "perf_ctry_flag": "1"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "537100",
   "pgm_ele_name": "SBIR Phase I"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "9181",
   "pgm_ref_txt": "BIOPROCESSING/BIOMOLECULAR MATERIALS"
  },
  {
   "pgm_ref_code": "BIOT",
   "pgm_ref_txt": "BIOTECHNOLOGY"
  }
 ],
 "app_fund": [
  {
   "app_code": "0103",
   "app_name": "NSF RESEARCH & RELATED ACTIVIT",
   "app_symb_id": "490100",
   "fund_code": "app-0103",
   "fund_name": "",
   "fund_symb_id": ""
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 2003,
   "fund_oblg_amt": 99999.0
  }
 ],
 "por": null
}